Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Treasury Shares (2019 - 2022)

Historic Treasury Shares for Serina Therapeutics (SER) over the last 4 years, with Q4 2022 value amounting to $3000.0.

  • Serina Therapeutics' Treasury Shares fell 8125.0% to $3000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $3000.0, marking a year-over-year decrease of 8125.0%. This contributed to the annual value of $3000.0 for FY2022, which is 8125.0% down from last year.
  • Per Serina Therapeutics' latest filing, its Treasury Shares stood at $3000.0 for Q4 2022, which was down 8125.0% from $6000.0 recorded in Q3 2022.
  • In the past 5 years, Serina Therapeutics' Treasury Shares registered a high of $50000.0 during Q4 2019, and its lowest value of $3000.0 during Q4 2022.
  • Its 4-year average for Treasury Shares is $20181.8, with a median of $19000.0 in 2021.
  • Its Treasury Shares has fluctuated over the past 5 years, first plummeted by 3870.97% in 2021, then tumbled by 8125.0% in 2022.
  • Over the past 4 years, Serina Therapeutics' Treasury Shares (Quarter) stood at $50000.0 in 2019, then crashed by 44.0% to $28000.0 in 2020, then plummeted by 42.86% to $16000.0 in 2021, then tumbled by 81.25% to $3000.0 in 2022.
  • Its Treasury Shares stands at $3000.0 for Q4 2022, versus $6000.0 for Q3 2022 and $9000.0 for Q2 2022.